Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
University of Dundee
Biotech
BMS, Merck KGa in protein degradation race with Amphista pacts
Bristol Myers Squibb and Merck KGaA have made further moves in the protein degrader space, inking deals with British biotech Amphista Therapeutics.
Max Bayer
May 4, 2022 8:00am
Gut link to Parkinson's sparks talk of probiotic treatment
Jan 14, 2020 11:00am
Sanofi inks €250M bispecific small molecule diabetes deal
May 9, 2017 3:00am
U.K. funds creation of antibiotic drug discovery unit
Mar 27, 2017 6:27am
Using a ‘kiss of death’ to neutralize disease-causing proteins
Mar 13, 2017 4:06pm
